| NCT06182358 | Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers | COMPLETED | PHASE4 | 2023-12-27 | 2025-01-27 | 2025-01-27 |
| NCT06054217 | Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-08-01 | 2024-06-15 | 2024-06-15 |
| NCT05838170 | Study of TP-04 in Participants With Papulopustular Rosacea | COMPLETED | PHASE2 | 2023-03-01 | 2023-11-13 | 2023-11-13 |
| NCT05720364 | Study to Evaluate the Food Effect of TP-05 in Healthy Participants | COMPLETED | PHASE1 | 2023-01-19 | 2023-05-30 | 2023-05-30 |
| NCT05387083 | A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05 | COMPLETED | PHASE2 | 2022-12-12 | 2024-06-26 | 2024-06-26 |
| NCT05454956 | Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD | COMPLETED | PHASE2 | 2022-08-03 | 2023-05-18 | 2023-05-18 |
| NCT05138796 | A Pharmacokinetic Study of TP-05 in Healthy Subjects | COMPLETED | PHASE1 | 2021-05-06 | 2022-07-25 | 2022-03-25 |
| NCT04784091 | Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis | COMPLETED | PHASE3 | 2021-04-29 | 2022-05-09 | 2022-05-09 |
| NCT05138861 | A Six Week Pharmacokinetic Study of TP-03 in Healthy Subjects | COMPLETED | PHASE1 | 2021-02-09 | 2021-09-03 | 2021-09-03 |
| NCT04475432 | Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis | COMPLETED | PHASE2, PHASE3 | 2020-09-09 | 2021-05-04 | 2021-05-04 |